News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100,430 Results
Type
Article (4600)
Company Profile (5)
Press Release (95825)
Multimedia
Podcasts (11)
Webinars (5)
Section
Business (29779)
Career Advice (33)
Deals (5884)
Drug Delivery (5)
Drug Development (13118)
Employer Resources (15)
FDA (3366)
Job Trends (1651)
News (52880)
Policy (4869)
Tag
Academia (234)
Accelerated approval (2)
Adcomms (2)
Allergies (5)
Alliances (9777)
ALS (17)
Alzheimer's disease (442)
Antibody-drug conjugate (ADC) (14)
Approvals (3387)
Artificial intelligence (16)
Autoimmune disease (3)
Automation (1)
Bankruptcy (17)
Best Places to Work (1266)
Biosimilars (32)
Biotechnology (7)
Bladder cancer (16)
Brain cancer (3)
Breast cancer (31)
Cancer (304)
Cardiovascular disease (39)
Career advice (34)
Career pathing (1)
CAR-T (4)
Cell therapy (41)
Cervical cancer (1)
Clinical research (10971)
Collaboration (122)
Compensation (11)
Complete response letters (2)
COVID-19 (277)
CRISPR (2)
C-suite (27)
Cystic fibrosis (5)
Data (343)
Depression (9)
Diabetes (32)
Diagnostics (749)
Digital health (2)
Diversity, equity & inclusion (4)
Drug discovery (20)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (22)
Earnings (10927)
Editorial (6)
Employer branding (8)
Employer resources (15)
Events (11124)
Executive appointments (91)
FDA (3637)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (85)
Gene editing (8)
Gene therapy (25)
GLP-1 (89)
Government (373)
Grass and pollen (1)
Guidances (24)
Healthcare (1783)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (14)
Indications (6)
Infectious disease (286)
Inflammatory bowel disease (20)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (19)
Interviews (1)
IPO (2070)
Job creations (441)
Job search strategy (34)
Kidney cancer (1)
Labor market (1)
Layoffs (39)
Legal (1218)
Liver cancer (25)
Lung cancer (52)
Lymphoma (18)
Management (3)
Manufacturing (42)
MASH (13)
Medical device (2642)
Medtech (2643)
Mergers & acquisitions (3929)
Metabolic disorders (74)
Multiple sclerosis (17)
NASH (3)
Neurodegenerative disease (30)
Neuropsychiatric disorders (5)
Neuroscience (535)
NextGen: Class of 2025 (497)
Non-profit (219)
Obesity (28)
Opinion (34)
Ovarian cancer (10)
Pain (11)
Pancreatic cancer (10)
Parkinson's disease (20)
Partnered (5)
Patents (37)
Patient recruitment (18)
People (7949)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (2966)
Phase II (4706)
Phase III (4182)
Pipeline (212)
Policy (4)
Postmarket research (474)
Preclinical (1106)
Press Release (2)
Prostate cancer (9)
Psychedelics (1)
Radiopharmaceuticals (26)
Rare diseases (54)
Real estate (792)
Recruiting (4)
Regulatory (3633)
Reports (7)
Research institute (206)
RSV (1)
Schizophrenia (12)
Series A (19)
Series B (12)
Service/supplier (1)
Sickle cell disease (7)
Special edition (3)
Spinal muscular atrophy (70)
Startups (629)
Stomach cancer (1)
Supply chain (9)
Tariffs (1)
The Weekly (11)
Vaccines (35)
Venture capitalists (2)
Weight loss (10)
Women's health (2)
Date
Today (24)
Last 7 days (114)
Last 30 days (390)
Last 365 days (4399)
2025 (1574)
2024 (4779)
2023 (5546)
2022 (9279)
2021 (8684)
2020 (7898)
2019 (5654)
2018 (4464)
2017 (5195)
2016 (4713)
2015 (5927)
2014 (4467)
2013 (3717)
2012 (3911)
2011 (4096)
2010 (3831)
Location
Africa (114)
Alabama (2)
Arizona (22)
Asia (22397)
Australia (2637)
California (636)
Canada (307)
China (187)
Colorado (12)
Connecticut (19)
Delaware (15)
Europe (15851)
Florida (93)
Georgia (18)
Idaho (1)
Illinois (34)
India (12)
Indiana (9)
Japan (93)
Kansas (13)
Louisiana (1)
Maine (5)
Maryland (100)
Massachusetts (488)
Michigan (11)
Minnesota (73)
Missouri (10)
Nebraska (1)
Nevada (6)
New Hampshire (4)
New Jersey (329)
New Mexico (2)
New York (232)
North Carolina (150)
Northern California (290)
Ohio (13)
Oklahoma (1)
Oregon (3)
Pennsylvania (103)
Puerto Rico (3)
Rhode Island (1)
South America (150)
South Carolina (3)
Southern California (221)
Tennessee (2)
Texas (60)
United States (2491)
Utah (21)
Virginia (29)
Washington D.C. (4)
Washington State (35)
West Virginia (1)
Wisconsin (6)
100,430 Results for "vascular biogenics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Sage Rejects Biogen’s Unsolicited Offer, Will Seek Strategic Alternatives
Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the embattled biotech at just $469 million.
January 27, 2025
·
1 min read
·
Annalee Armstrong
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
Announcing first-quarter results, Biogen CEO Chris Viehbacher admitted that tariffs are “a new topic for us,” but said he does not expect major impacts—at least for 2025.
May 1, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Legal
Sage Sues Partner Biogen After Unsolicited Takeover Offer
Biogen’s effort to buy Sage reveals its “desire to expand its pipeline at a discount,” according to analysts from BMO Capital Markets.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Spectrum Vascular Welcomes New Executive Leadership
April 14, 2025
·
4 min read
Neuroscience
Biogen Submits Offer to Buy Embattled Partner Sage
Biogen’s proposed acquisition comes after two difficult years of regulatory and clinical challenges, during which shares of Sage Therapeutics have fallen by more than 90%.
January 13, 2025
·
3 min read
·
Heather McKenzie
Accelerated approval
Inspector General Questions FDA’s Accelerated Approval for Biogen, Sarepta Drugs
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, Sarepta’s Exondys and Covis’ Makena.
January 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vasorum Announces FDA Approval of its Celt ACD® PLUS Vascular Closure Device
March 28, 2025
·
3 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Podcast
RFK Jr. Faces the Senate, Sage Rebuffs Biogen, Obesity Space Expands, More
Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees more action with new company launches, IPOs and fresh data; and experts get ready for an important era in the Duchenne muscular dystrophy space.
January 29, 2025
·
1 min read
·
Heather McKenzie
1 of 10,043
Next
